Novel imaging techniques for diabetic macular edema

Documenta Ophthalmologica

Volumn 97, Issue 3-4, 1999, Pages 341-347

  Lobo, Conceição ^a,b   Bernardes, Rui ^a   De Abreu, J R Faria ^a   Cunha Vaz, José G ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Diabetes; Edema; Imaging; Retinal leakage analyser; Retinal thickness analyser; Retinopathy

Indexed keywords

DIAGNOSTIC AGENT;

DIABETIC RETINOPATHY; DIAGNOSTIC IMAGING; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER; METHODOLOGY; OPHTHALMOSCOPY; PATHOLOGY; PERIMETRY; RETINA; RETINA MACULA CYSTOID EDEMA; RETINA MACULA LUTEA; REVIEW; TOMOGRAPHY;

DIABETIC RETINOPATHY; DIAGNOSTIC IMAGING; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; LASERS; MACULA LUTEA; MACULAR EDEMA, CYSTOID; OPHTHALMOSCOPY; PERIMETRY; RETINA; TOMOGRAPHY;

EID: 0033289485     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1002479823690     Document Type: Article

References (11)

1. King H. The epidemic of NIDDM: an epidemiological prespective. Int Diab Fed Bull 1995; 40: 10-12.
2. Cohadon F. Protection Cérébrale. Bases Conceptuelles et Applications. Paris: Arnette Blackwell, 1995; 1-184.
3. Cunha-Vaz JG, Travassos A. Breakdown of the Blood-Retinal Barriers and Cystoid Macular Edema. Surv Ophthalmol 1984; 28 (suppl): 465-92.
4. Zeimer R, Mori MT, Khoobehi B. Feasibility test of a new method to measure retinal thickness noninvasively. Invest Ophthalmol Vis Sci 1989; 30: 2099-105.
5. Lobo C, Isidore I, Simões PC, Leite E, Sander B, Cunha-Vaz JG. Topographic vitreous fluorometry using a modifed confocal laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 1996; 37 (suppl.): 611.
6. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular disease with optical coherence tomography. Ophthalmology 1995; 102: 217-29.
7. Murta JN, Serra, Cunha-Vaz JG. Characterization of D-glucose transport across diabetic retinal vessels. Invest Ophthalmol Vis Sci 1996; 37 (suppl.): 979.
8. van Enden M, Nyengaard J, Ostrair E, Burgan JH, Williamson JR. Elevated glucose levels increase retinal glycolysis and sorbitol pathway mechanisms. Invest Ophthalmol Vis Sci 1995; 36: 1675-85.
9. Corbett JÁ, Tilton RG, Chang K, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 41: 552-6.
10. Parving H, Larsen M, Hossonel E et al. Effect of antihypertensive treatment on bloodretinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 1989; 32: 441-4.
11. Cunha-Vaz JG, Lobo C. Medical therapy of diabetic retinopathy. Exp Ophthalmol 1998; 24: 1-5.